Management of Hyperphosphataemia in Chronic Kidney Disease: Summary of National Institute for Health and Clinical Excellence (NICE) Guideline

Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) guideline.

Bone disease and ectopic calcification are the two main consequences of hyperphosphataemia of chronic kidney disease (CKD). Observational studies have demonstrated that hyperphosphataemia in CKD is associated with increased mortality. Furthermore, the use of phosphate binders in dialysis patients is associated with significantly lower mortality. The UK Renal Registry data show significant under...

Is National Institute of Clinical Excellence (NICE) guideline a nice guideline?

The National Institute for Clinical Excellence (NICE).

In discussions on the development of the institutional framework for decisions on the benefit package of social health insurance in Germany, the English National Institute for Clinical Excellence (NICE) is considered as either a good or a bad example for reform. According to this study, the procedures and criteria applied by NICE for making health care coverage decisions are legitimate. Procedu...

National Institute for Health and Clinical Excellence (NICE) guideline: psychosis with coexisting substance misuse.

This editorial summarizes the main recommendations of the NICE guideline on psychosis and coexisting substance misuse. It outlines the dearth of specific evidence (especially for integrated models), but emphasizes implementation of evidence for the treatment of psychosis and substance misuse separately for current best practice and policy. It highlights research options and training needs to fu...

National Clinical Guideline Centre cost-effectiveness assessment for the National Institute for Health and Clinical Excellence.

The National Clinical Guideline Centre (NCGC) develops evidence-based clinical guidelines on behalf of the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom. The U.K. Department of Health has commissioned NICE to make recommendations on the basis of both clinical effectiveness and cost-effectiveness. This article describes how cost-effectiveness is evaluated and...